These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2496522)

  • 1. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
    Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
    Conner JR; Hornick JL
    Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonectin--a differentiation marker of bone cells.
    Jundt G; Berghäuser KH; Termine JD; Schulz A
    Cell Tissue Res; 1987 May; 248(2):409-15. PubMed ID: 3581152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
    Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
    J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of osteonectin in various types of osteosarcoma.
    Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
    Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological demonstration of osteonectin in normal bone tissue and in bone tumors.
    Schulz A; Jundt G
    Curr Top Pathol; 1989; 80():31-54. PubMed ID: 2776495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
    Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
    Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YJ5 as an immunohistochemical marker of osteogenic lineage.
    Chua K; Virshup DM; Odono EG; Chang KTE; Tan NJH; Hue SS; Sim AYL; Lee VKM
    Pathology; 2021 Feb; 53(2):229-238. PubMed ID: 33187685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
    Davis JL; Horvai AE
    Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
    Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
    Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin expression in bone tumours and tumour-like lesions.
    Inagaki Y; Hookway ES; Kashima TG; Munemoto M; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
    Histopathology; 2016 Sep; 69(3):470-8. PubMed ID: 26896083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
    Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
    Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin expression in skeletal sarcomas.
    Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
    Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours.
    Kashima TG; Dongre A; Oppermann U; Athanasou NA
    Virchows Arch; 2013 May; 462(5):583-91. PubMed ID: 23559304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK; Yang MH; Park HR
    Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone matrix production in osteosarcoma].
    Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
    Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.